Dark

Check out our Level2View

BVXV
BiondVax Pharmaceuticals Ltd
stock NASDAQ

Inactive

Sep 6, 2023

1.36USD+3.817%(+0.05)23,023

Pre-market

0.00USD-100.000%(-1.31)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 26, 2022

10:28AM EST Aegis Capital Initiates Coverage On BiondVax Pharmaceuticals with Buy Rating, Announces Price Target of $7 Benzinga

07:40AM EST BiondVax to Present at Edison Group's Open House Conference PR Newswire

Jan 10, 2022

07:01AM EST BiondVax to Present at H.C. Wainwright Bioconnect Virtual Conference PR Newswire

Dec 29, 2021

04:01PM EST BiondVax Announces Successful Closing of $9.8 million Follow-on Underwritten PR Newswire

Dec 28, 2021

10:51AM EST Mid-Morning Market Update: Markets Mostly Higher; Digital Turbine Reports Multi-Year Collaboration With Google Benzinga

08:56AM EST Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Dec. 28, 2021: KNSA, BVXV, FTK, APPS, MBOT Benzinga

05:36AM EST BiondVax Shares Rise More than 100% Premarket; Co Announced on Monday the Former GSK Vaccines CFO Joined the BiondVax Board of Directors Benzinga

Dec 27, 2021

04:07PM EST BiondVax Pharma Appoints Jay Green To Board Of Directors RTTNews

04:01PM EST Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's PR Newswire

02:57PM EST Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher Benzinga

12:23PM EST Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge Benzinga

10:20AM EST Mid-Morning Market Update: Markets Open Higher; News Corp To Buy Base Chemicals Benzinga

06:47AM EST BiondVax Prices Offering Of ~3.81M ADSs At $2.36/ADS Benzinga

06:47AM EST BiondVax Announces Pricing Of 3.81 Mln ADSs Follow-on Underwritten Offering At $2.36 Per ADS For About $9.0 Mln RTTNews

06:45AM EST BiondVax Announces Pricing of $9.0 million Follow-on Underwritten Offering of PR Newswire

Dec 26, 2021

09:53AM EST The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year Benzinga

Dec 23, 2021

08:01PM EST BiondVax Announces Proposed Underwritten Public Offering of American Depositary PR Newswire

Dec 22, 2021

11:40AM EST Shares of nano-cap company BiondVax Pharmaceuticals Ltd. (BVXV) nearly doubled after the biopharmaceutical company announced that it has inked definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Gttingen, Germany. RTTNews

07:28AM EST BiondVax Signs Deals For Development And Commercialization RTTNews

07:21AM EST Biondvax Signs Definitive Agreements For Development And Commercialization Of Nanosized COVID-19 Antibody Therapy With Max Planck Institute Of Biophysical Chemistry And University Medical Center Gttingen, Germany Benzinga

07:13AM EST BiondVax Signs Agreements For Development And Commercialization Of Nanosized COVID-19 Antibody Therapy; Stock Surges RTTNews

07:08AM EST innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Gttingen, Germany PR Newswire

Nov 30, 2021

07:06AM EST BiondVax announces Third Quarter 2021 Financial Results and Provides Business PR Newswire

Nov 24, 2021

01:47PM EST BiondVax Announces Notice of Annual General Meeting of Shareholders and PR Newswire

Nov 15, 2021

05:15AM EST BiondVax to Present at H.C. Wainwright 7th Annual Israel Conference PR Newswire

Oct 19, 2021

08:00AM EDT BiondVax, Max Planck, UMG To Enter Into 5-year Research Collaboration Incl Option For BiondVax To License VHH Antibodies RTTNews

07:56AM EDT BiondVax Pharmaceuticals Signs Term Sheet For 'broad-based strategic collaboration' With Max Planck Society And University Medical Center Gttingen Benzinga

07:54AM EDT BiondVax advances its growth strategy towards a new pipeline based on PR Newswire

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Aug 26, 2021

04:13PM EDT BiondVax Pharmaceuticals Q2 EPS $(0.10) Down From $(0.03) YoY Benzinga

04:05PM EDT BiondVax Announces Second Quarter 2021 Financial Results and Provides Business PR Newswire

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Jul 21, 2021

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jun 23, 2021

06:09AM EDT BiondVax Q1 Loss Per Share NIS 0.02 Vs Loss NIS 0.01 Last Year RTTNews

06:08AM EDT BiondVax Pharmaceuticals Q1 EPS $(0.01) Up From $(0.04) YoY Benzinga

06:01AM EDT BiondVax Announces First Quarter 2021 Financial Results and Provides Business PR Newswire

May 13, 2021

05:30PM EDT BiondVax Pharmaceuticals FY21 EPS $(0.01) Down From $(0.00) YoY Benzinga

04:55PM EDT BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results and PR Newswire

Mar 23, 2021

07:46AM EDT BiondVax CEO ISsues Shareholder Letter Benzinga

07:45AM EDT Letter from BiondVax's New CEO to Shareholders PR Newswire

Feb 10, 2021

04:30PM EST BiondVax Announces Exercise in Full of Underwriter's Over-Allotment Option in PR Newswire

Feb 2, 2021

04:30PM EST BiondVax Announces Closing of $12.1 Million Follow-on Underwritten Offering PR Newswire

Jan 29, 2021

08:06AM EST BiondVax Announces Pricing Of $12.1 Mln Follow-on Underwritten Offering Of American Depositary Shares RTTNews

07:59AM EST BiondVax Prices 2,434,783 ADS Offering At $4.95/ADS Benzinga

07:58AM EST BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of PR Newswire

07:45AM EST The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO Benzinga

Jan 28, 2021

07:51PM EST BiondVax Announces Launch Of Proposed Underwritten Follow-on Offering Of ADSs RTTNews

06:49PM EST BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of PR Newswire

03:28PM EST BiondVax Pharmaceuticals Q3 Operating Income NIS 55.6M Benzinga

03:24PM EST BiondVax Announces Third Quarter 2020 Financial Results & Business Update PR Newswire

Jan 21, 2021

07:18AM EST BiondVax Appoints Amir Reichman As CEO, Effective March 2, 2021 RTTNews

07:16AM EST BiondVax Announces Appointment Of Amir Reichman As New CEO Benzinga

Nov 10, 2020

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 9, 2020

10:09AM EST Stocks Trading Near 52-Week Lows Just After Open On Monday, Nov. 9, 2020: ABCM, SOAC, KOR, BVXV, HPR, BIIB, CTRM, TTNP, ASMB Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Oct 29, 2020

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 28, 2020

08:59AM EDT Stocks Trading Near 52-Week Lows Before Open On Wednesday, Oct. 28, 2020: OXY, CTRM, PBF, BVXV, RIDE, FRO, CATB, NVCN, EURN, WFC, PSHG, MFGP, ZSAN, KERN, BP Benzinga

Oct 27, 2020

09:02AM EDT Stocks Trading Near Their 52-Week Lows Before Open On Tuesday, Oct. 27, 2020: CATB, DBVT, ITRM, BVXV, BUR Benzinga

09:01AM EDT Stocks Trading Near 52-Week Lows Before Open On Tuesday, Oct. 27, 2020: CATB, DBVT, ITRM, BVXV, BUR Benzinga

Oct 26, 2020

10:18AM EDT Mid-Morning Market Update: Markets Open Lower; Hasbro Reports Upbeat Profit Benzinga

Oct 23, 2020

03:47PM EDT Mid-Afternoon Market Update: Boston Beer Jumps On Upbeat Results; Limelight Networks Shares Plummet Benzinga

12:29PM EDT /C O R R E C T I O N -- BiondVax Pharmaceuticals Ltd./ PR Newswire

11:07AM EDT BiondVax Pharma Shares To Resume Trade At 11:10 a.m. EDT Benzinga

10:41AM EDT BiondVax Reports Topline Results From Phase 3 Trial Of M-001 Universal Flu Vaccine Candidate Benzinga

10:41AM EDT BiondVax Announces Results From Phase 3 Trial Of The M-001 Universal Influenza Vaccine Candidate RTTNews

10:39AM EDT BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 PR Newswire

09:19AM EDT BiondVax Pharmaceutical Shares Halted At 9:12 a.m. EDT For Pending News Benzinga

Oct 2, 2020

06:02AM EDT BiondVax Announces At-The-Market Equity Offering Program RTTNews

06:01AM EDT BiondVax Pharma Reports $100M At-The-Market Offering Benzinga

06:00AM EDT BiondVax Announces At-The-Market (ATM) Equity Offering Program PR Newswire

Aug 20, 2020

04:04PM EDT BiondVax Pharmaceuticals Q2 EPS $(0.10) Up From $(0.18) YoY Benzinga

04:01PM EDT BiondVax Announces Second Quarter 2020 Financial Results PR Newswire

Aug 13, 2020

04:01PM EDT BiondVax Announces Notice of Annual General Meeting of Shareholders and PR Newswire

Jul 14, 2020

11:31AM EDT Mid-Morning Market Update: Markets Mostly Lower; JPMorgan Tops Q2 Views Benzinga

05:11AM EDT 80 Biggest Movers From Yesterday Benzinga

Jul 13, 2020

02:31PM EDT Mid-Afternoon Market Update: Dow Jumps 400 Points; Equillium Shares Spike Higher Benzinga

10:13AM EDT Mid-Morning Market Update: Markets Open Higher; PepsiCo Beats Q2 Estimates Benzinga

Share